Default: Gynecologic Oncology

ISSN: 0090-8258

Journal Home

Journal Guideline

Gynecologic Oncology Q1 Unclaimed

Academic Press Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Gynecologic Oncology is a journal indexed in SJR in Obstetrics and Gynecology and Oncology with an H index of 157. It has an SJR impact factor of 2,463 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

Gynecologic Oncology

2,463

SJR Impact factor

157

H Index

377

Total Docs (Last Year)

1190

Total Docs (3 years)

11215

Total Refs

4978

Total Cites (3 years)

1110

Citable Docs (3 years)

4,3

Cites/Doc (2 years)

29,75

Ref/Doc


Best articles

A 104-year-old woman with advanced cervical carcinoma of the uterus

View more

A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)

View more

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

View more

A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies

View more

A Prospective Controlled Trial of Early Postoperative Oral Intake Following Major Abdominal Gynecologic Surgery

View more

Accelerating gastrointestinal recovery in women undergoing ovarian cancer debulking: A randomized, double-blind, placebo-controlled trial

View more

Allelic Losses at Chromosome 3p Are Seen in Human Papilloma Virus 16 Associated Transitional Cell Carcinoma of the Cervix

View more

An analysis of 84,244 patients from the British Columbia cytology-colposcopy program

View more

An integrated molecular profile of endometrioid ovarian cancer

View more

Apoptosis May Be an Early Event of Progestin Therapy for Endometrial Hyperplasia

View more

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

View more

BARD1, a possible biomarker for breast and ovarian cancer

View more
SHOW MORE ARTICLES

Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy

View more

Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue

View more

Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women

View more

Clinical trial methodology in rare gynecologic tumor research: Strategies for success

View more

Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix

View more

Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus

View more

Comparative study of laparoscopico-vaginal radical hysterectomy and abdominal radical hysterectomy in patients with early cervical cancer

View more

Conservative surgery for borderline ovarian tumors: A review

View more

Cystadenocarcinoma of the abdominal wall following caesarean section: case report and review of the literature

View more

Development and Assessment of a General Theory of Cervical Carcinogenesis Utilizing a Severe Combined Immunodeficiency Murine-Human Xenograft Model

View more

Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: A single center experience

View more

Disparities in care among patients with low-grade serous ovarian carcinoma

View more

Comments

No comments ... Be the first to comment!